Item 8.01. Other Events. Explanatory Note Regarding Voluntary Filing This Current Report on Form 8-K is being filed voluntarily by ProText Mobility, Inc. (OTC PINK/OTCID: TXTM) (the "Company") pursuant to Item 8.01 of Form 8-K under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company is a former SEC reporting company (CIK No. 0001163573, Commission File No.…
Filed Jun 15, 2026Accepted Jun 15, 2026, 12:32 PM EDTCIK 1163573Accession 0001140361-26-025137
ProText Mobility, Inc. (OTC: TXTM) is a Delaware corporation pursuing international development opportunities across biotechnology, agricultural and pharmaceutical infrastructure, proprietary technologies, real-world assets and emerging digital financial infrastructure. The Company’s strategic initiatives encompass proprietary live plant extraction technologies, active pharmaceutical ingredient development, agricultural biotechnology, digital-asset systems, institutional financial frameworks and international commercial relationships.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events.
Explanatory Note Regarding Voluntary Filing
This Current Report on Form 8-K is being filed voluntarily by ProText Mobility, Inc. (OTC PINK/OTCID: TXTM) (the "Company") pursuant to Item 8.01 of Form 8-K under the
Securities Exchange Act of 1934, as amended (the "Exchange Act").
The Company is a former SEC reporting company (CIK No. 0001163573, Commission File No. 001-31590) that is voluntarily submitting this Form 8-K to introduce into the
public record on the SEC's EDGAR system a press release and corporate disclosure disseminated through GlobeNewswire and the OTC Markets news channel.
This voluntary filing is being made as part of the Company's ongoing efforts to enhance transparency, strengthen its public disclosure practices, and prepare for a
potential uplisting to a national securities exchange. The press release attached hereto as Exhibit 99.1 was originally published and publicly disseminated on 06/12/2026.
The Company does not by this filing assume any obligation to file current reports under Section 13 or 15(d) of the Exchange Act beyond what may otherwise be required by
applicable law.
Filing Status
The information contained in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being deemed "filed" for purposes of Section 18 of the Exchange
Act and shall be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, to the extent not superseded by information contained in any such subsequent filing.
On 06/12/2026, the Company issued a press release announcing the launch of its new corporate website and investor relations platform and providing a shareholder update
regarding the Company's biotechnology, pharmaceutical infrastructure, digital systems, international strategic relationship, and exchange-uplisting initiatives. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
Filed exhibits (1)
EX-99.1 (by filename) ef20076160_ex99-1.htm
EX-99.1
2
ef20076160_ex99-1.htm
PRESS RELEASE DATED 06/12/2026 - PROTEXT MOBILITY INC. (OTCID: TXTM) UNVEILS NEW CORPORATE WEBSITE AND INVESTOR RELATIONS PLATFORM TO SUPPORT STRATEGIC GROWTH AND EXCHANGE UPLISTING
Exhibit 99.1
Protext Mobility Inc. (OTCID: TXTM) Unveils New Corporate Website and Investor Relations Platform to Support Strategic Growth and Exchange Uplisting
June 12, 2026 09:34 ET | Source: ProText Mobility, Inc.
ENGINEERING THE INFRASTRUCTURE LAYER BETWEEN BIOLOGY, PHARMACEUTICAL SCIENCE & DIGITAL CAPITAL
FORT LAUDERDALE, Fla., June 12, 2026 (GLOBE NEWSWIRE) -- Protext Mobility Inc. (OTCID: TXTM) is pleased to provide shareholders, prospective investors, and strategic
partners with an update regarding the continued evolution of the Company and the significant progress being made across its biotechnology, pharmaceutical infrastructure, and digital systems initiatives.
Over the past several years, while much of the market focused on short-term volatility, our team remained committed to quietly building the foundational infrastructure
necessary to support a much larger long-term vision.
Today, Protext Mobility stands positioned at the convergence of biology, …